Please upgrade your browser.
To evaluate the prognostic impact of the histological expression of CD133 in renal cell carcinoma (RCC).
To evaluate frequency of renin detection in chromophobe renal cell carcinoma, and if this expression was associated to systemic high blood pressure.
Paper highlights clinical and immunological activity of IMA901 in renal cell carcinoma (RCC)
The genetic determinants of sporadic renal cell cancer (RCC) are largely unknown. Previous studies have suggested associations between ABO blood group and risk of various cancers.
Fibronectin 1 (FN1) is a glycoprotein involved in cellular adhesion and migration processes. The aim of this study was to elucidate the role of FN1 in development of renal cell cancer and to determine a prognostic relevance for optimal clinical management.
Among patients with early stage (pT1) renal cell carcinoma (RCC), a larger kidney size is associated with an increased the risk of dying from the malignancy, new data show.
The diagnosis of cancer impacts every aspect of an individualâs life and comprises an array of physical and psychosocial distress. Join us as Michele OâBrien discusses the âSeasons of Survivorshipâ - defining survivorship, how it changes through the journey and how you can advocate for yourself or a loved one in the healthcare world.
Previous reports of cancer after kidney transplantation have been limited by small numbers of patients in single-center studies and incomplete ascertainment of cases in large registries.
U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) discussed the question: Would an imaging test provide useful clinical information if it identified only clear cell renal cell carcinoma (ccRCC) within the kidney of patients with an indeterminate renal mass?
Leading Genomic Testing Sales Force Expands Market Reach and Access; Precision Therapeutics to Begin Marketing miRviewÂ® mets(2) in August
|Powered by NeonCRM|